NASDAQ:INKT

MiNK Therapeutics, Inc.

Read INKT's Filings Free

Company facts

Headquarters
New York, New York
Most recent report
10-Q, filed Aug 13, 2026
Incorporated
Delaware
Filings on record
258 filings
On EDGAR
CIK 1840229
Fiscal year ends
December
Filer status
Non-accelerated filer Smaller reporting company Emerging growth company

Financials 8 of 20

News 8 of 42

Prospectuses and Registrations 8 of 16

Proxies 8

Ownership 8 of 146

Other 8 of 26

Everything here comes from MiNK Therapeutics, Inc.'s own filings on SEC EDGAR. The filing list is rechecked every hour.